Form 4 for ASTH Astrana Health, Inc.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-15 · accession 0001104659-23-126910 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-18 | 2023-12-15 | ASTH | Schmidt David | Dir | A - Grant | $0.00 | +5,750 | 5,750 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | A | A | 5,750 | $0.00 | 5,750 | D | — | — | (F1) Restricted shares of the Issuer's common stock granted pursuant to the Issuer's 2015 Equity Incentive Plan, which shall vest on December 9, 2024 (or if earlier, upon the date of the Reporting Person's cessation of service on the Issuer's board of directors). (F2) Includes 5,750 shares of restricted stock, which will vest on December 9, 2024. |